<DOC>
	<DOCNO>NCT00825188</DOCNO>
	<brief_summary>Obesity hypertension independent risk congestive heart failure ( CHF ) chronic kidney disease . In obesity induce hypertension , common cause human essential hypertension , potential importance mineralocorticoid receptor blockade widely investigate . We propose test hypothesis eplerenone reduce metabolic demand , improve cardiac function attenuate glomerular hyperfiltration microalbuminuria obese patient . Our specific aim assess change basal metabolic rate , cardiac renal function obese hypertensive subject treat eplerenone compare amlodipine .</brief_summary>
	<brief_title>A Study Effects Eplerenone Amlodipine Blood Pressure Basal Metabolic Rate Obese Hypertensives</brief_title>
	<detailed_description>The propose trial utilize open label study design . Patients hypertension obesity recruit . After 3-week washout period patient currently antihypertensive medication , eligible participant assign receive 25 mg eplerenone 5 mg amlodipine . After 4 week period medication , drug advance 50 mg eplerenone 10 mg amlodipine additional 4 week . Protocol Synopsis : 1 . Recruit 20 study participant systolic blood pressure ( SBP ) 140 160 mmHg and/or diastolic blood pressure 90 100 mmHg also body mass index &gt; 30-45 . If participant antihypertensive treatment , undergo 3-week washout period . The study participant identify Division Hypertension . 2 . Assign study participant receive 25 mg eplerenone 5 mg amlodipine per day 4 week . Up-titration eplerenone 50 mg amlodipine 10 mg additional 4 week . 3 . Obtain basal metabolic rate , cardiac output index cardiac performance , cognitive ability , rating depression anxiety symptom baseline 8 week treatment . 4 . Obtain blood pressure measure visit . 5 . Obtain mood rating visit . 6 . Compare basal metabolic rate , cardiac output index cardiac performance treatment group . 7 . Compare difference SBP DBP treatment group . 8 . Compare differences plasma insulin , serum electrolyte , plasma renin activity , cortisol aldosterone concentration , urinary albumin excretion , glomerular filtration rate treatment group . 9 . Compare mood rating well symptoms depression anxiety treatment group .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Eplerenone</mesh_term>
	<mesh_term>Spironolactone</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Systolic blood pressure ( SBP ) 140 160 mmHg and/or diastolic blood pressure 90 100 mmHg also body mass index &gt; 3045 . Women must post menopausal Women child bear potential BMI le 30 great 45 A creatinine &gt; 1.8 female &gt; 2.0 male Type 1 type 2 diabetes Current evidence alcohol drug abuse problem</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>